Deprecated: Creation of dynamic property cls_session::$session_data_table is deprecated in /www/sites/www.188bio.com/index/systems/cls_session.php on line 49
tecomedical/ELISA Complement Activity Analysis/20 µl (dilute 1:20 for plasma); 10 µl (dilute 1:50 for serum)/A025188bio精品生物—专注于实验室精品爆款的电商平台 - 蚂蚁淘旗下精选188款生物医学科研用品
您好,欢迎您进入188进口试剂采购网网站! 服务热线:4000-520-616
蚂蚁淘商城 | 现货促销 | 科研狗 | 生物在线
产品资料

tecomedical/ELISA Complement Activity Analysis/20 µl (dilute 1:20 for plasma); 10 µl (dilute 1:50 for serum)/A025

ELISA Complement Activity Analysis

Product name

C5a MicroVue™ Quidel®

Measurement of terminal complement pathway activation in experimental samples

Cat-Nr.A025
Range0.1 - 1 ng/ml
SensitivityLOD: 0.01 ng/ml; LLOQ: 0.050 ng/ml
Incubation time2 hours 15 minutes
Sample volume20 µl (dilute 1:20 for plasma); 10 µl (dilute 1:50 for serum)
Sample type

Serum, EDTA- and citrated plasma.

Sample preparation

The proper collection, storage and shipment of specimens are essential. Test immediately or stored up to 4 hours at 2-8 ºC or on ice. For longer-term storage the samples should kept frozen at -70 ºC with stabilizing solution (Cat. No. A9576), dilute samples 1:1 with stabilizing solution.

Reference values

EDTA Plasma 0.37 – 74.33 ng/ml Serum 13.37 – 179.23 ng/ml

Species

Human

Specificity

C5a and C5a des-Arg

Tests96
MethodELISA
Intended use

C5a is generated as a result of cleavage of the terminal complement protein C5,during activation of the complement system via the classical, alternative or lectin pathway. C5a is a low molecular weight (approximately 9 kD) protein fragment of 74 amino acids. C5 a is rapidly metabolized by the serum enzyme carboxypeptidase to more stable, less active, 73 amino acid form, C5a des-Arg.

Research has associated elevated levels of fluid phase and adsorbed C5a with hemo-incompatibility of some biomaterials, particularly in extracorporeal circuits. Levels of C5a have also been associated with pathogenesis of a variety of disease states, including myocardial infarction, stroke, as well as vascular leak syndrome and associated kidney injury. The role of C5a in the pathogenesis of malaria and other infectious diseases, as well as sepsis, is likewise well documented.

Product informations
Kit Instructions (PDF 907,3 kB)
Cross-reaction all species (PDF 74,6 kB)
Monitoring Complement Activation SC5b-9, C5a &CH50 (PDF 99,7 kB)
Measurement of Complement Activation in Human Disease (PDF 4,6 MB)
Hemocompatibility (PDF 6,4 MB)
Information (PDF 1,1 MB)

Back to overview

新闻动态
行业前沿
技术文章
最新产品